FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research uncovers hidden Australian skin cancer epidemic

2.

Chemoimmunotherapy Boosts Head and Neck Cancer Response

3.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

4.

New research uncovers link between cancer pathway and blood-retina barrier function

5.

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot